Melanoma survival refined

The Melanoma Severity Index (MSI) incorporates clinical and demographic factors using data dating back to 1995 from the Queensland Cancer Registry, supplemented by pathology reports.

The model was presented last week at the inaugural Global Controversies and Advances in Skin Cancer Conference 2013, hosted by the Cancer Council in Brisbane.

Tools such as the American Joint Committee on Cancer’s Melanoma Patient Outcome Prediction Tool (MPOPT) use age, sex and depth of the tumour but